Valuation: Becton, Dickinson and Company

Market Cap 48.16B 42.79B 39.94B 36.4B 68.65B 4,630B 69.29B 483B 187B 2,367B 181B 177B 7,596B P/E 2026 *
34.1x
P/E 2027 * 19x
Enterprise Value 64.04B 56.9B 53.11B 48.41B 91.29B 6,157B 92.14B 643B 249B 3,147B 240B 235B 10,101B EV / Sales 2026 *
3.32x
EV / Sales 2027 * 3.15x
Free-Float
73.18%
Yield 2026 *
2.22%
Yield 2027 * 2.26%
1 day-1.44%
1 week-2.11%
Current month-0.55%
1 month-5.51%
3 months+14.22%
6 months+14.94%
Current year-8.44%
1 week 176.22
Extreme 176.22
187.5
1 month 174.85
Extreme 174.85
188.55
Current year 139.58
Extreme 139.58
212.51
1 year 139.58
Extreme 139.58
212.51
3 years 139.58
Extreme 139.58
269.21
5 years 139.58
Extreme 139.58
286.33
10 years 139.58
Extreme 139.58
286.33
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer 56 04/12/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%-2.11% - - 48.16B
+0.84%-3.74%-26.69%+1.85% 169B
-0.07%-2.55%-9.53%+11.07% 110B
+0.90%+1.13%-24.83%+0.58% 106B
-1.24%-0.76%-49.04%-12.75% 73.87B
-0.24%+0.69%+0.16%+72.58% 58.98B
-0.86%+2.96%+13.57%+59.50% 51.28B
-0.71%-3.82%-7.72%-31.41% 48.16B
+0.12%-0.17%-18.21%+20.29% 40.84B
-1.01%-1.45%+28.48%-9.72% 32.21B
Average -0.37%-0.86%-10.42%+12.44% 76.69B
Weighted average by Cap. -0.07%-1.30%-16.36%+10.13%

Financials

2026 *2027 *
Net sales 19.28B 17.13B 15.99B 14.57B 27.48B 1,853B 27.74B 193B 74.96B 947B 72.37B 70.8B 3,040B 19.73B 17.53B 16.36B 14.91B 28.13B 1,897B 28.39B 198B 76.74B 970B 74.09B 72.48B 3,112B
Net income 1.44B 1.28B 1.19B 1.09B 2.05B 138B 2.07B 14.42B 5.59B 70.6B 5.39B 5.28B 227B 2.34B 2.08B 1.94B 1.77B 3.34B 225B 3.37B 23.48B 9.1B 115B 8.78B 8.59B 369B
Net Debt 15.88B 14.11B 13.17B 12.01B 22.64B 1,527B 22.86B 159B 61.77B 781B 59.64B 58.35B 2,505B 13.95B 12.4B 11.57B 10.55B 19.89B 1,341B 20.07B 140B 54.25B 686B 52.38B 51.24B 2,200B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
02/10/26 USD 176.47 -0.55% 263
01/10/26 USD 177.45 -1.47% 654
30/09/26 USD 180.10 -0.88% 89
29/09/26 USD 181.69 -0.98% 100
28/09/26 USD 183.48 +0.27% 866
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
176.80USD
Average target price
195.67USD
Spread / Average Target
+10.67%

Quarterly revenue - Rate of surprise